Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Control : Journal of the Moffitt Cancer Center|October 8, 2025
A Hybrid Technology-Enabled Financial Navigation Model to Combat Financial Toxicity in Cancer CareDinesh Pal Mudaranthakam, Allison Makovec, Rachel Forcino, et al.
Translational Lung Cancer Research|March 11, 2026
Discovery of a novel <i>ITPR2::KRAS</i> fusion in large cell neuroendocrine lung cancer: a case reportAnthony J Patregnani, Rejowana Rouf, David R Moline, et al.
Cancers|April 26, 2025
The Influence of the Germline <i>HSD3B1</i> Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate CancerSamuel Kellen, Allison Makovec, Carly D Miller, et al.
Iscience|October 7, 2025
SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancerEmil Lou, Christine Luo, Katherine Ladner, et al.
Oncotarget|July 25, 2025
Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancerAiden Deacon, Ava Gustafson, Allison Makovec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient GroupsAllison Makovec, Ava P Gustafson, Nishant Gandhi, et al.
International Journal of Molecular Sciences|June 26, 2025
<i>HSD3B1</i> (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial CancersNikitha Vobugari, Allison Makovec, Samuel Kellen, et al.
NPJ Precision Oncology|August 7, 2025
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancerAllison Makovec, Ella Boytim, Ava Gustafson, et al.
Oncotarget|April 9, 2026
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancerAllison Makovec, John T Phoenix, Hannah E Bergom, et al.
Cancer Research Communications|May 6, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human MalignanciesCarly D Miller, John R Lozada, Nicholas A Zorko, et al.
Pageof 2